ABU DHABI, UAE — In the past 9 months, a surge of new trials related to the management of intracranial hemorrhage (ICH) has led the European Stroke Organisation (ESO) to delay issuing a planned ...
Dual antiplatelet therapy with clopidogrel and aspirin can benefit patients with mild ischemic stroke when initiated up to 72 hours after symptom onset.
Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with ...